Carolina Wealth Advisors, LLC Novo Nordisk A S Transaction History

Carolina Wealth Advisors, LLC

$179 Million
Q4 2024

A detailed history of Carolina Wealth Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Carolina Wealth Advisors, LLC holds 1,656 shares of NVO stock, worth $150,464. This represents 0.08% of its overall portfolio holdings.

Number of Shares

1,656

Previous 405 308.89%

Holding current value

$150,464

Previous $48,000 195.83%

% of portfolio

0.08%

Previous 0.03%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 14, 2025	BUY	$85.0 - $120.04 $106,335 - $150,170	1,251 Added 308.89%	1,656 $142,000
Q3 2024 Oct 21, 2024	BUY	$119.07 - $145.42 $48,223 - $58,895	405 New	405 $48,000
Q1 2022 Apr 18, 2022	SELL	$93.1 - $112.54 $4.26 Million - $5.15 Million	-45,739 Closed	0 $0
Q4 2021 Jan 24, 2022	BUY	$95.88 - $117.08 $227,619 - $277,947	2,374 Added 5.47%	45,739 $5.12 Million
Q3 2021 Oct 22, 2021	BUY	$84.42 - $106.62 $93,284 - $117,815	1,105 Added 2.61%	43,365 $4.16 Million
Q2 2021 Jul 22, 2021	BUY	$67.66 - $84.76 $110,082 - $137,904	1,627 Added 4.0%	42,260 $3.54 Million
Q1 2021 Apr 09, 2021	BUY	$67.06 - $75.82 $107,966 - $122,070	1,610 Added 4.13%	40,633 $2.74 Million
Q4 2020 Jan 29, 2021	SELL	$63.89 - $73.8 $235,562 - $272,100	-3,687 Reduced 8.63%	39,023 $2.73 Million
Q3 2020 Oct 19, 2020	SELL	$63.69 - $70.22 $14,712 - $16,220	-231 Reduced 0.54%	42,710 $2.97 Million
Q2 2020 Jul 31, 2020	BUY	$58.54 - $67.94 $18,381 - $21,333	314 Added 0.74%	42,941 $2.81 Million
Q1 2020 Apr 09, 2020	BUY	$49.46 - $64.78 $10,089 - $13,215	204 Added 0.48%	42,627 $2.57 Million
Q4 2019 Feb 07, 2020	BUY	$49.86 - $58.26 $2.12 Million - $2.47 Million	42,423 New	42,423 $2.46 Million

Others Institutions Holding NVO

# of Institutions

1,882

Shares Held

336M

Call Options Held

11.9M

Put Options Held

10.6M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $205B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Carolina Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Carolina Wealth Advisors, LLC with notifications on news.

Account

Carolina Wealth Advisors, LLC Novo Nordisk A S Transaction History